---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-25-122777"
form_type: "8-K"
ticker: "NEUP"
cik: "0001191070"
company_name: "Neuphoria Therapeutics Inc."
filed_at: "2025-12-17T23:59:59+00:00"
generated_at: "2026-05-16T12:53:33.978286+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# Neuphoria Therapeutics Announces Annual Meeting Voting Results; Elects Two Class I Directors

## Summary
- Shareholders elected Peter Miles Davies (759,850 votes for) and David Wilson (758,571) as Class I directors.
- Ratification of Wolf & Company P.C. as auditor passed with 807,022 votes in favor.
- Non-binding advisory vote on executive compensation approved with 726,184 votes for.
- On frequency of advisory votes, three years received the most votes (585,857), though non-binding.
- Approximately 39.76% of outstanding shares (937,447) were represented at the meeting.

## SEC filing metadata
- accession: 0001213900-25-122777
- form_type: 8-K
- ticker: NEUP
- cik: 0001191070
- company_name: Neuphoria Therapeutics Inc.
- filed_at: 2025-12-17T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1191070/000121390025122777/0001213900-25-122777-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1191070/000121390025122777/ea0270035-8k_neuphoria.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-25-122777
- JSON: https://secwatch.observer/filing/0001213900-25-122777.json
- Plain text: https://secwatch.observer/filing/0001213900-25-122777.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.